Retrospective Observational Study of Outcomes in HER2-Positive Metastatic Breast Cancer (mBC) Patients Treated with Ado-Trastuzumab Emtansine (T-DM1) and Subsequent Treatments After T-DM1 in the United States

• Main Authors: Neelima Denduluri (Author), Janet L. Espirito (Author), Michelle D. Hackshaw (Author), Chuck Wentworth (Author), Tamy Recchia (Author), Winghan J. Kwong (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Limited evidence exists on real-world outcomes with ado-trastuzumab emtansine (T-DM1) treatment and the effectiveness of subsequent therapies. Objective This study evaluated treatment patterns and outcomes of patients treated with T-DM1 and post-T-DM1 therapy in the United States...